106 related articles for article (PubMed ID: 24400091)
1. Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs.
Hinrichsen I; Kemp M; Peveling-Oberhag J; Passmann S; Plotz G; Zeuzem S; Brieger A
PLoS One; 2014; 9(1):e84453. PubMed ID: 24400091
[TBL] [Abstract][Full Text] [Related]
2. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
[TBL] [Abstract][Full Text] [Related]
4. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.
Win AK; Reece JC; Buchanan DD; Clendenning M; Young JP; Cleary SP; Kim H; Cotterchio M; Dowty JG; MacInnis RJ; Tucker KM; Winship IM; Macrae FA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
Fam Cancer; 2015 Dec; 14(4):575-83. PubMed ID: 26202870
[TBL] [Abstract][Full Text] [Related]
5. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
[TBL] [Abstract][Full Text] [Related]
6. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.
Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z
Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
8. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
[No Abstract] [Full Text] [Related]
9. Immunohistochemical Analysis of Mismatch Repair Gene Proteins in Early Gastric Cancer Based on Microsatellite Status.
Sugimoto R; Endo M; Osakabe M; Toya Y; Yanagawa N; Matsumoto T; Sugai T
Digestion; 2021; 102(5):691-700. PubMed ID: 33053554
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the MLH1, MLH2, MLH6, PMS2 genes and their correlations with clinical data in rectal mucinous adenocarcinoma.
Graur F; Puia A; Mois E; Pop P; Berar M; Elisei R; Zaharie F; Nechita V; Rusu I; Buiga R; Puia C; Al Hajjar N
Ann Ital Chir; 2022; 93():188-194. PubMed ID: 34807001
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma.
Csepregi A; Ebert MP; Röcken C; Schneider-Stock R; Hoffmann J; Schulz HU; Roessner A; Malfertheiner P
BMC Cancer; 2010 Jun; 10():317. PubMed ID: 20569442
[TBL] [Abstract][Full Text] [Related]
12. Morphological predictors for microsatellite instability in urothelial carcinoma.
Sobrino-Reig E; Meizoso T; García J; Varillas-Delgado D; Martin YB
Diagn Pathol; 2021 Nov; 16(1):106. PubMed ID: 34801034
[TBL] [Abstract][Full Text] [Related]
13. Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications.
Ban X; Mo S; Lu Z; Jia C; Shao H; Chang X; Mao X; Zhang Y; Pang J; Zhang Y; Yu S; Chen J
Endocrine; 2022 Sep; 77(3):538-545. PubMed ID: 35708896
[TBL] [Abstract][Full Text] [Related]
14. Pms2 suppresses large expansions of the (GAA·TTC)n sequence in neuronal tissues.
Bourn RL; De Biase I; Pinto RM; Sandi C; Al-Mahdawi S; Pook MA; Bidichandani SI
PLoS One; 2012; 7(10):e47085. PubMed ID: 23071719
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in mismatch repair genes are associated with risk and microsatellite instability of gastric cancer, and interact with life exposures.
Zhu H; Li X; Zhang X; Chen D; Li D; Ren J; Gu H; Shu Y; Wang D
Gene; 2016 Mar; 579(1):52-7. PubMed ID: 26724419
[TBL] [Abstract][Full Text] [Related]
16. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146
[TBL] [Abstract][Full Text] [Related]
17. High levels of circulating folate concentrations are associated with DNA methylation of tumor suppressor and repair genes
Sanchez H; Hossain MB; Lera L; Hirsch S; Albala C; Uauy R; Broberg K; Ronco AM
Clin Epigenetics; 2017; 9():74. PubMed ID: 28748002
[TBL] [Abstract][Full Text] [Related]
18. Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications.
Dutta P; Pal D; Roy A; Mandal RK; Panda CK
Gene; 2023 Dec; 888():147746. PubMed ID: 37657688
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p53 mutation and mismatch repair proteins dysregulation in NNK-induced malignant transformation of human bronchial epithelial cells.
Shen Y; Zhang S; Huang X; Chen K; Shen J; Wang Z
Biomed Res Int; 2014; 2014():920275. PubMed ID: 25215298
[TBL] [Abstract][Full Text] [Related]
20. Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular carcinoma.
Sun G; Zhang C; Feng M; Liu W; Xie H; Qin Q; Zhao E; Wan L
Medicine (Baltimore); 2017 Oct; 96(41):e8279. PubMed ID: 29019900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
